Anavex Life Sciences (AVXL) Earnings Analysis

Anavex Life Sciences (AVXL) next reports earnings on 2026-07-23, consensus EPS -0.07 USD. Last quarter (2026-02-09) it beat with EPS -0.06 USD vs -0.1 USD est (+40%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E -5.50.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does AVXL next report earnings?

Next earnings date2026-07-23
Consensus EPS estimate-0.07 USD
Revenue estimaten/a

AVXL earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-09-0.06 USD-0.1 USD+40%Beat
2025-11-25-0.11 USD-0.13 USD+15.4%Beat
2025-02-12-0.14 USD-0.17 USD+17.6%Beat
2024-12-23-0.14 USD-0.17 USD+17.6%Beat

Beat rate: 4/4 (100%) over reported quarters with consensus data.

AVXL valuation and analyst view

Trailing P/E-5.50
Trailing EPS-0.44869 USD
Price / book1.79
Dividend yield0.00%
Market cap0.23B
Analyst consensusBuy (11 buy / 2 hold / 0 sell)

Related research pages

Frequently asked questions

When is Anavex Life Sciences (AVXL)'s next earnings date?

Anavex Life Sciences is next scheduled to report on 2026-07-23, with a consensus EPS estimate of -0.07 USD.

Did AVXL beat earnings last quarter?

In its 2026-02-09 report, AVXL posted EPS of -0.06 USD versus a -0.1 USD estimate — a beat of 40%.

What is AVXL's earnings track record?

Over the last 4 reported quarters with consensus data, AVXL beat estimates 4 times (100%).

What is AVXL's current P/E ratio and EPS?

AVXL trades at a trailing P/E of -5.50 on trailing EPS of -0.44869418389585164 USD.

What do analysts rate AVXL?

Analyst consensus is "Buy" across 13 ratings (0 strong buy, 11 buy, 2 hold, 0 sell, 0 strong sell).